Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia - A randomized study

Supportive Care in Cancer

Volumn 12, Issue 2, 2004, Pages 99-105

  Johansson, Eva ^a   Björkholm, Magnus ^a   Björvell, Hjördis ^b   Hast, Robert ^a   Takolander, Rabbe ^a   Olofsson, Per ^a   Backman, Lars ^c   Weitzberg, Eddie ^a   Engervall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Central venous catheter; Implantable vascular access device; Leukaemia

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; FLUCONAZOLE;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEVICE INFECTION; DRUG IMPLANT; FEMALE; HUMAN; INFECTIOUS COMPLICATION; LEUKEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; VASCULAR ACCESS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DRUG DELIVERY SYSTEMS; FEMALE; HEMORRHAGE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 10744233488     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0558-1     Document Type: Article

References (23)

1. Biffi R, de Braud F, Orsi F, et al (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767-773
2. Björkholm M (1994) Chemoprophylaxis of fungal infections in neutropenic patients. Ann Oncol 5:571-574
3. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intem Med 64:328-340
4. Brincker H, Saeter G (1986) Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer 57:1124-1129
5. Carde P, Cosset-Delaigue M, Laplanche A, Chareau I (1989) Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumours. Eur J Cancer Clin Oncol 25:939-944
6. Engervall P, Björkholm M (1995) Infections in neutropenic patients I: aetiology. Med Oncol 12:251-256
7. Engervall P, Ringertz S, Hagman E, et al (1995) Change of central venous catheter dressings twice a week is superior to once a week in patients with haematological malignancies. J Hosp Infect 29:275-286
8. Engervall P, Gunther G, Ljungman P, et al (1996) Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever. Scand J Infect Dis 28:297-303
9. Groeger J, Lucas A, Thaler H, et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174
10. Hartkamp A, Boxtel A, Zonnenberg B, Witteven P (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215-223
11. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Soc 53:457-481
12. Kappers-Klunne M, Degener J, Stijnen T, Abels J (1989) Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer 64:1747-1752
13. Kock H, Pietsch M, Krause U, et al (1998) Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22:12-16
14. Mueller B, Skelton J, Callender D, et al (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943-1948
15. O'Grady NP, Alexander M, Dellinger EP, et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recommendations and Reports, vol 51, no. RR10;1, pp 1-26
16. Pagano L, Taconelli E, Tumbarello M, et al (1997) Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 82:415-419
17. Peto R, Pike MC, Armitage P, et al (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39
18. Peuges D, Axelrod P, McClarren C, et al (1992) Comparison of infections in hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 49:156-162
19. Platzbecker U, Illmer T, Schaich M, et al (2001) Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Bone Marrow Transplant 28:1067-1072
20. Raad I, Baba M, Bodey G (1995) Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 20:593-597
21. Reilly J, Steed D, Ritter P (1984) Indwelling venous access catheters in patients with acute leukemia. Cancer 53:219-223
22. Schiffer CA, Anderson KC, Bennett CL, et al (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1519-1538
23. Soo KC, Davidson TI, Selby P, Westbury G (1985) Long-term venous access using a subcutaneous implantable drug delivery system. Ann R Coll Surg Engl 67:263-265